ANI PHARMACEUTICALS INC — Director's Dealing 2020

May 13, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2020-05-11

Reporting Person: Walsh Patrick D (Director, Interim President and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-11	Common Stock	A	7050	—	Acquired	20096	Direct

Footnotes

F1: The restricted stock was granted to the Reporting Person in connection with his commencement as interim President and Chief Executive Officer of the issuer. The restricted stock vests on the earlier of (i) May 11, 2021 or (ii) the termination of the Reporting Person's service as interim President and Chief Executive Officer, except in connection with a "for cause" termination.